FDA Aims To Explain Itself Better With New Transparency Task Force
This article was originally published in The Gray Sheet
Executive Summary
FDA's newly formed transparency task force will try to identify more effective ways to explain controversial agency decisions to the public
You may also be interested in...
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
FDA Unveils 21 Policy Changes To Increase Transparency With Public
FDA may publicly disclose more information on specific devices prior to marketing approval under a May 19 proposal to increase transparency
HHS Open Government Plan Offers Vastly More Information On FDA, CMS
The Department of Health and Human Services' open government plan, unveiled April 7, includes an online "FDA Track" site to measure FDA's performance and a "CMS Dashboard" that provides easier access to certain Medicare payment data